Opponents of embryonic stem cell research, which involves destroying the donated embryos from which cell lines are derived, have long argued that the discovery of iPS cells in 2006 (for which Shinya Yamanaka was awarded the Nobel Prize in Medicine this past year) obviates the need for embryonic stem cell research.
Scientists found however, that feeder cells and serums derived from other animal cells introduced disease-causing agents that compromised the quality of the cell lines.